DSFIR.AS: DSM-Firmenich AG Financials
DSM-Firmenich AG Income Statement
Total revenue
Net income
Gross margin TTM
39.07%
Operating margin TTM
7.87%
Net profit margin TTM
-11.97%
Return on investment TTM
-5.93%
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 9,034,000,000 | 12,799,000,000 | 10,627,000,000 | 8,390,000,000 |
| Operating income | 711,000,000 | 561,000,000 | -497,000,000 | 682,000,000 |
| Net income | -1,081,000,000 | 250,000,000 | 2,137,000,000 | 460,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 9,034,000,000 | 12,799,000,000 | 10,627,000,000 | 8,390,000,000 |
| Cost of revenue | 5,504,000,000 | 8,554,000,000 | 8,016,000,000 | 5,609,000,000 |
| Gross profit | 3,530,000,000 | 4,245,000,000 | 2,611,000,000 | 2,781,000,000 |
| Research and development expenses | 0 | 0 | 652,000,000 | 295,000,000 |
| General and administrative expenses | 925,000,000 | 1,038,000,000 | 1,015,000,000 | 534,000,000 |
| Selling and marketing expenses | 1,281,000,000 | 1,801,000,000 | 1,512,000,000 | 1,235,000,000 |
| Selling, general and administrative expenses | 2,206,000,000 | 2,848,000,000 | 2,527,000,000 | 1,769,000,000 |
| Other expenses | 613,000,000 | 836,000,000 | -71,000,000 | -56,000,000 |
| Operating expenses | 2,819,000,000 | 3,684,000,000 | 3,108,000,000 | 2,008,000,000 |
| Cost and expenses | 8,323,000,000 | 12,238,000,000 | 11,124,000,000 | 7,665,000,000 |
| Net interest income | -108,000,000 | -116,000,000 | -67,000,000 | -45,000,000 |
| Interest income | 60,000,000 | 70,000,000 | 95,000,000 | 22,000,000 |
| Interest expense | 168,000,000 | 186,000,000 | 162,000,000 | 67,000,000 |
| Depreciation and amortization | 3,122,000,000 | 1,090,000,000 | 1,307,000,000 | 652,000,000 |
| EBITDA | 3,851,000,000 | 561,000,000 | 822,000,000 | 1,313,000,000 |
| EBIT | 711,000,000 | 561,000,000 | -485,000,000 | 661,000,000 |
| Non-operating income (excl. interest) | 0 | 0 | -12,000,000 | 30,000,000 |
| Operating income | 711,000,000 | 561,000,000 | -497,000,000 | 682,000,000 |
| Total other income/expenses (net) | -254,000,000 | -134,000,000 | -157,000,000 | -83,000,000 |
| Income before tax | 460,000,000 | 427,000,000 | -647,000,000 | 599,000,000 |
| Income tax expense | 118,000,000 | 147,000,000 | -18,000,000 | 124,000,000 |
| Net income from continuing operations | 342,000,000 | 280,000,000 | -636,000,000 | 475,000,000 |
| Net income from discontinued operations | -1,381,000,000 | -79,000,000 | 2,789,000,000 | 1,240,000,000 |
| Other adjustments to net income | 0 | 0 | -2,796,000,000 | -1,240,000,000 |
| Net income | -1,081,000,000 | 250,000,000 | 2,137,000,000 | 460,000,000 |
| Net income deductions | 0 | 0 | 0 | 0 |
| Bottom line net income | -1,081,000,000 | 250,000,000 | -658,000,000 | 454,000,000 |
| EPS | -4 | 0.94 | -3 | 3 |
| Diluted EPS | -4 | 0.94 | -3 | 3 |
| Weighted average shares outstanding | 259,300,000 | 264,600,000 | 233,200,000 | 172,800,000 |
| Weighted average diluted shares outstanding | 259,300,000 | 264,600,000 | 233,200,000 | 173,300,000 |
DSM-Firmenich AG Balance Sheet
Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
3,617,000,000%
Total debt / assets MRQ
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total assets | 29,345,000,000 | 33,747,000,000 | 34,270,000,000 | 17,403,000,000 |
| Total liabilities | 10,922,000,000 | 11,050,000,000 | 11,200,000,000 | 6,558,000,000 |
| Total equity | 18,244,000,000 | 22,511,000,000 | 22,908,000,000 | 10,743,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Cash and cash equivalents | 1,782,000,000 | 2,667,000,000 | 2,456,000,000 | 2,755,000,000 |
| Short-term investments | 121,000,000 | 50,000,000 | 107,000,000 | 125,000,000 |
| Cash and short-term investments | 1,903,000,000 | 2,717,000,000 | 2,563,000,000 | 2,880,000,000 |
| Net receivables | 2,099,000,000 | 2,718,000,000 | 2,553,000,000 | 1,508,000,000 |
| Accounts receivable | 1,841,000,000 | 2,589,000,000 | 2,553,000,000 | 1,508,000,000 |
| Other receivables | 258,000,000 | 129,000,000 | 0 | 0 |
| Inventory | 2,121,000,000 | 3,290,000,000 | 3,390,000,000 | 2,339,000,000 |
| Prepaid expenses | 0 | 0 | 0 | 0 |
| Other current assets | 2,770,000,000 | 74,000,000 | 338,000,000 | 1,401,000,000 |
| Total current assets | 8,893,000,000 | 8,799,000,000 | 8,844,000,000 | 8,128,000,000 |
| Property, plant and equipment (net) | 4,174,000,000 | 5,725,000,000 | 5,549,000,000 | 3,576,000,000 |
| Goodwill | 9,447,000,000 | 11,247,000,000 | 11,293,000,000 | 2,984,000,000 |
| Intangible assets | 5,937,000,000 | 6,831,000,000 | 7,445,000,000 | 2,163,000,000 |
| Goodwill and intangible assets | 15,384,000,000 | 18,078,000,000 | 18,738,000,000 | 5,147,000,000 |
| Long-term investments | 259,000,000 | 292,000,000 | 867,000,000 | 438,000,000 |
| Tax assets | 227,000,000 | 299,000,000 | 228,000,000 | 303,000,000 |
| Other non-current assets | 408,000,000 | 554,000,000 | 293,000,000 | 19,000,000 |
| Total non-current assets | 20,452,000,000 | 24,948,000,000 | 25,675,000,000 | 9,483,000,000 |
| Other assets | 0 | 0 | -249,000,000 | 0 |
| Total assets | 29,345,000,000 | 33,747,000,000 | 34,270,000,000 | 17,403,000,000 |
| Total payables | 1,784,000,000 | 2,499,000,000 | 2,063,000,000 | 1,475,000,000 |
| Accounts payable | 1,481,000,000 | 2,276,000,000 | 2,063,000,000 | 1,411,000,000 |
| Other payables | 303,000,000 | 223,000,000 | 0 | 64,000,000 |
| Accrued expenses | 274,000,000 | 517,000,000 | 584,000,000 | 324,000,000 |
| Short-term debt | 1,583,000,000 | 836,000,000 | 632,000,000 | 44,000,000 |
| Capital lease obligations (current) | 77,000,000 | 90,000,000 | 84,000,000 | 44,000,000 |
| Tax payables | 303,000,000 | 223,000,000 | 177,000,000 | 64,000,000 |
| Deferred revenue | 6,000,000 | 0 | 0 | 4,000,000 |
| Other current liabilities | 1,869,000,000 | 935,000,000 | 1,156,000,000 | 667,000,000 |
| Total current liabilities | 5,593,000,000 | 4,360,000,000 | 4,519,000,000 | 2,558,000,000 |
| Long-term debt | 3,617,000,000 | 4,010,000,000 | 3,783,000,000 | 2,843,000,000 |
| Capital lease obligations (non-current) | 386,000,000 | 434,000,000 | 331,000,000 | 135,000,000 |
| Deferred revenue (non-current) | 31,000,000 | 0 | 70,000,000 | 55,000,000 |
| Deferred tax liabilities (non-current) | 1,351,000,000 | 1,556,000,000 | 1,751,000,000 | 476,000,000 |
| Other non-current liabilities | -77,000,000 | 690,000,000 | 746,000,000 | 491,000,000 |
| Total non-current liabilities | 5,329,000,000 | 6,690,000,000 | 6,681,000,000 | 4,000,000,000 |
| Other liabilities | 0 | 0 | 0 | 0 |
| Capital lease obligations | 463,000,000 | 524,000,000 | 415,000,000 | 179,000,000 |
| Total liabilities | 10,922,000,000 | 11,050,000,000 | 11,200,000,000 | 6,558,000,000 |
| Treasury stock | -1,208,000,000 | -147,000,000 | -44,000,000 | -196,000,000 |
| Preferred stock | 0 | 0 | 0 | 0 |
| Common stock | 3,000,000 | 3,000,000 | 3,000,000 | 328,000,000 |
| Retained earnings | 8,406,000,000 | 10,632,000,000 | 10,744,000,000 | 9,777,000,000 |
| Additional paid-in capital | 10,934,000,000 | 11,313,000,000 | 11,731,000,000 | 471,000,000 |
| Accumulated other comprehensive income/loss | 109,000,000 | 710,000,000 | 474,000,000 | 363,000,000 |
| Other stockholders' equity | 0 | 0 | 0 | 0 |
| Total stockholders' equity | 18,244,000,000 | 22,511,000,000 | 22,908,000,000 | 10,743,000,000 |
| Total equity | 18,423,000,000 | 22,697,000,000 | 23,070,000,000 | 10,845,000,000 |
| Minority interest | 179,000,000 | 186,000,000 | 162,000,000 | 102,000,000 |
| Total liabilities and total equity | 29,345,000,000 | 33,747,000,000 | 34,270,000,000 | 17,611,000,000 |
| Total investments | 380,000,000 | 342,000,000 | 974,000,000 | 563,000,000 |
| Total debt | 5,663,000,000 | 5,370,000,000 | 4,830,000,000 | 3,064,000,000 |
| Net debt | 3,881,000,000 | 2,703,000,000 | 2,374,000,000 | 309,000,000 |
DSM-Firmenich AG Cash Flow Statement
Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Cash from operations | 1,388,000,000 | 1,778,000,000 | 1,265,000,000 | 923,000,000 |
| Cash from investing | 392,000,000 | -252,000,000 | -726,000,000 | 871,000,000 |
| Cash from financing | -2,582,000,000 | -1,334,000,000 | -820,000,000 | -598,000,000 |
| Net change in cash | -885,000,000 | 211,000,000 | -299,000,000 | 1,194,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Net income | 340,000,000 | 250,000,000 | 2,137,000,000 | 460,000,000 |
| Depreciation and amortization | 899,000,000 | 1,186,000,000 | 1,307,000,000 | 652,000,000 |
| Deferred income tax | 0 | 0 | 0 | -1,797,000,000 |
| Stock-based compensation | 38,000,000 | 0 | 29,000,000 | 34,000,000 |
| Change in working capital | -210,000,000 | 198,000,000 | 160,000,000 | -497,000,000 |
| Accounts receivable | -16,000,000 | -18,000,000 | 49,000,000 | -133,000,000 |
| Inventory | -89,000,000 | -38,000,000 | 89,000,000 | -442,000,000 |
| Accounts payable | 5,000,000 | 97,000,000 | 126,000,000 | 116,000,000 |
| Other working capital | -110,000,000 | 157,000,000 | -104,000,000 | -38,000,000 |
| Other non-cash items | 321,000,000 | 1,330,000,000 | -2,368,000,000 | 2,071,000,000 |
| Net cash from operating activities | 1,388,000,000 | 1,778,000,000 | 1,265,000,000 | 923,000,000 |
| Investments in property, plant and equipment | -764,000,000 | -764,000,000 | -555,000,000 | -644,000,000 |
| Acquisitions (net) | 1,251,000,000 | 30,000,000 | -158,000,000 | 1,314,000,000 |
| Purchases of investments | 0 | 0 | -150,000,000 | -671,000,000 |
| Sales/maturities of investments | 0 | 0 | 195,000,000 | 1,031,000,000 |
| Other investing activities | -95,000,000 | 482,000,000 | -58,000,000 | -159,000,000 |
| Net cash from investing activities | 392,000,000 | -252,000,000 | -726,000,000 | 871,000,000 |
| Net debt issuance | -579,000,000 | 248,000,000 | -569,000,000 | 1,000,000 |
| Long-term net debt issuance | -579,000,000 | 248,000,000 | -569,000,000 | 1,000,000 |
| Short-term net debt issuance | 0 | 0 | 0 | 0 |
| Net stock issuance | -1,176,000,000 | -685,000,000 | 501,000,000 | -185,000,000 |
| Net common stock issuance | -1,176,000,000 | -685,000,000 | 501,000,000 | -185,000,000 |
| Common stock issuance | 5,000,000 | 21,000,000 | 757,000,000 | 25,000,000 |
| Common stock repurchased | -1,181,000,000 | -706,000,000 | -256,000,000 | -210,000,000 |
| Net preferred stock issuance | 0 | 0 | 0 | 0 |
| Net dividends paid | -718,000,000 | -667,000,000 | -582,000,000 | -345,000,000 |
| Common dividends paid | -718,000,000 | -667,000,000 | -157,000,000 | -345,000,000 |
| Preferred dividends paid | 0 | 0 | -425,000,000 | 0 |
| Other financing activities | -109,000,000 | -230,000,000 | -170,000,000 | -69,000,000 |
| Net cash from financing activities | -2,582,000,000 | -1,334,000,000 | -820,000,000 | -598,000,000 |
| Effect of FX changes on cash | -83,000,000 | 19,000,000 | -18,000,000 | -2,000,000 |
| Net change in cash | -885,000,000 | 211,000,000 | -299,000,000 | 1,194,000,000 |
| Cash at end of period | 1,782,000,000 | 2,667,000,000 | 2,456,000,000 | 2,755,000,000 |
| Cash at beginning of period | 2,667,000,000 | 2,456,000,000 | 2,755,000,000 | 1,561,000,000 |
| Operating cash flow | 1,388,000,000 | 1,778,000,000 | 1,265,000,000 | 923,000,000 |
| Capital expenditure | -764,000,000 | -764,000,000 | -555,000,000 | -644,000,000 |
| Free cash flow | 624,000,000 | 1,014,000,000 | 710,000,000 | 279,000,000 |
| Income taxes paid | 0 | 0 | 0 | 0 |
| Interest paid | 0 | 0 | 0 | 0 |